➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Johnson and Johnson
Moodys
Medtronic
Mallinckrodt

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

FLUOCINOLONE ACETONIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Fluocinolone Acetonide patents expire, and when can generic versions of Fluocinolone Acetonide launch?

Fluocinolone Acetonide is a drug marketed by Acp Nimble, Alpharma Us Pharms, Fougera Pharms Inc, Invatech, Perrigo New York, Pharmafair, Taro, Usl Pharma, Akorn, Identi Pharms Inc, Lyne, Perrigo Israel, Pharmaderm, Actavis Labs Ut Inc, Bausch And Lomb, Encube Ethicals, Glasshouse Pharms, Lupin, and Morton Grove. and is included in forty-nine NDAs.

The generic ingredient in FLUOCINOLONE ACETONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

US ANDA Litigation and Generic Entry Outlook for Fluocinolone Acetonide

A generic version of FLUOCINOLONE ACETONIDE was approved as fluocinolone acetonide by TARO on April 27th, 1982.

  Start Trial

Drug patent expirations by year for FLUOCINOLONE ACETONIDE
Drug Prices for FLUOCINOLONE ACETONIDE

See drug prices for FLUOCINOLONE ACETONIDE

Recent Clinical Trials for FLUOCINOLONE ACETONIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Pradeepa YoganathanPhase 2
St. Michael's Hospital, TorontoPhase 2
Alimera SciencesPhase 4

See all FLUOCINOLONE ACETONIDE clinical trials

Pharmacology for FLUOCINOLONE ACETONIDE
Medical Subject Heading (MeSH) Categories for FLUOCINOLONE ACETONIDE

US Patents and Regulatory Information for FLUOCINOLONE ACETONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 040059-001 Dec 20, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Acp Nimble FLUOCINOLONE ACETONIDE fluocinolone acetonide OINTMENT;TOPICAL 089524-001 Jul 26, 1988 AT RX No No   Start Trial   Start Trial   Start Trial
Taro FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 089124-001 Sep 11, 1985 AT RX No No   Start Trial   Start Trial   Start Trial
Invatech FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 088048-001 Dec 16, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo Israel FLUOCINOLONE ACETONIDE fluocinolone acetonide OIL;TOPICAL 202847-001 Aug 9, 2013 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Johnson and Johnson
Moodys
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.